Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

If you need an accessible version of this item please contact JSTOR User Support

Reduction in Incidence of Nosocomial Methicillin‐Resistant Staphylococcus aureus (MRSA) Infection in an Intensive Care Unit: Role of Treatment With Mupirocin Ointment and Chlorhexidine Baths for Nasal Carriers of MRSA

Ana Maria Sandri , MD, Micheline Gisele Dalarosa , MD, Luciana Ruschel de Alcântara , MD, Laura da Silva Elias , MD and Alexandre Prehn Zavascki , MD, PhD
Infection Control and Hospital Epidemiology
Vol. 27, No. 2 (February 2006), pp. 185-187
DOI: 10.1086/500625
Stable URL: http://www.jstor.org/stable/10.1086/500625
Page Count: 3
  • Subscribe ($19.50)
  • Cite this Item
Item Type
Article
References
If you need an accessible version of this item please contact JSTOR User Support
Reduction in Incidence of Nosocomial Methicillin‐Resistant Staphylococcus aureus (MRSA) Infection in an Intensive Care Unit: Role of Treatment With Mupirocin Ointment and Chlorhexidine Baths for Nasal Carriers of MRSA
Preview not available

Abstract

After the introduction of routine treatment for every nasal carrier of methicillin‐resistant Staphylococcus aureus, active follow‐up surveillance for nosocomial methicillin‐resistant S. aureus infection was conducted for 5 years in an intensive care unit of a tertiary‐care teaching hospital. There was a significant decrease in the incidence of nosocomial methicillin‐resistant S. aureus infection during the later years of follow‐up. Decolonization of nasal carriers of methicillin‐resistant S. aureus is probably associated with such findings.

Page Thumbnails